Human PD-L1 inhibitor II 10876 N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O |^1:0|

N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O |^1:0|

thereby demonstrating the protective role of CXCR7 modulation with CXCR7 modulator 2 in an isoproterenol-induced cardiac injury

27(10): 1432-1445

and the chemo-proteomics approach demonstrated the superior selectivity of TMP269 relative to the other hydroxamate-substituted analogs via a chelating zinc-binding group

also known as ICI-118

Human PD-L1 inhibitor II 10876 N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(O)=O |^1:0|Human PD L1 inhibitor II is a potent PD L1 inhibitor with anti cancer activity. Product information CAS Number: 2135542 85 5 Chemical Name: Human PD L1 inhibitor II Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of Analysis) Shipping Condition: Shipped under ambient temperature as non hazardous chemical or refer to Certificate of Analysis Storage Condition: Dry, dark and 20 oC for 1 year or refer to the Certificate of